Telix Pharmaceuticals Limited

DB:T3X Stock Report

Market Cap: €4.2b

Telix Pharmaceuticals Limited Company Information

Telix Pharmaceuticals Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Telix Pharmaceuticals Limited
  • Ticker: T3X
  • Exchange: DB
  • Founded: 2015
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$6.840b
  • Listing Market Cap: AU$4.217b
  • Shares Outstanding: 334.65m
  • Website: https://telixpharma.com

Number of Employees


Location

  • Telix Pharmaceuticals Limited
  • 55 Flemington Road
  • Suite 401
  • North Melbourne
  • Victoria
  • 3051
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TLXASX (Australian Securities Exchange)YesOrdinary SharesAUAUDNov 2017
TLXCHIA (Chi-X Australia)YesOrdinary SharesAUAUDNov 2017
TLPP.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDNov 2017
T3XDB (Deutsche Boerse AG)YesOrdinary SharesDEEURNov 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/09/27 09:24
End of Day Share Price 2024/09/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.